Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
NeuLogiq® Platform Confirms Electrophysiological Marker of Target Engagement in…
The poster titled, "A Phase Ib Study to Evaluate the Pharmacodynamics, Safety, and Tolerability of the Novel Neuroplastogen DLX-001 in Participants with Major Depressive Disorder: Interim Findings," was presented by Aaron Koenig, MD, Chief Medical Officer at Delix Therapeutics and featured data confirming the Cumulus NeuLogiq® Platform detected a pharmacodynamic signal consistent with that previously observed in a phase I healthy volunteer study. A consistent increase in slow-wave…
PR Newswire
29/05/2025
Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence
The FDA inspection, conducted with meticulous detail, evaluated Medicilon's organizational structure, personnel qualifications, SOPs, facilities integrity, documentation processes, experimental operations, quality assurance systems, and computerized infrastructures. Inspectors also reviewed several research projects submitted to the FDA. The FDA inspection, conducted with meticulous detail, evaluated Medicilon's organizational structure, personnel qualifications, SOPs, facilities integrity,...
PR Newswire
29/05/2025
Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners…
Its precision-engineered capabilities make it the ideal choice for practitioners seeking transformative results with minimal downtime, reduced patient discomfort and speedy healing. Complementing UltraClear, the AuraLux laser leverages the same exclusive Cool Pulse™ technology and broadens accessibility for aesthetic providers and their patients while maintaining Acclaro's hallmark quality. Its precision-engineered capabilities make it the ideal choice for practitioners seekingtransformative...
PR Newswire
29/05/2025
uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in…
~ No serious adverse events and 92% reduction in seizure frequency observed in the first trial participant through first five months of follow up ~~ Data to be presented today at Epilepsy Therapies & Diagnostics Development Symposium (ETDD) ~ LEXINGTON, Mass. and AMSTERDAM, May29, 2025(GLOBE NEWSWIRE) --uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the presentation of a...
Nasdaq GlobeNewswire
29/05/2025
Alkermes to Present New Research Related to ALKS 2680 at SLEEP 2025
DUBLIN, May 29, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new research related to ALKS 2680 at SLEEP 2025, the 38th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 8-11, 2025 in Seattle. ALKS 2680 is the company's novel, investigational, oral orexin 2 receptor (OX2R) agonist in phase 2 development as a once-daily treatment for narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH). DUBLIN...
PR Newswire
29/05/2025
Brainomix Driving Treatment Decisions in Stroke: New Studies Presented at…
Dr Albert Yoo (Texas Stroke Institute) presented results from a research collaboration between Brainomix and the TESLA Trial team, whose randomized study was originally published in JAMA in September 2024. In this new analysis of the trial data, Brainomix 360 Stroke was used to estimate the ischemic core volume and degree of hypoattenuation on the non-contrast CT (NCCT) scans taken upon admission for the 276 large vessel occlusion (LVO) patients included in the original study. The results showed…
PR Newswire
29/05/2025
AI Meets Audit Powerhouse: Qualifyze Launches Quality Insights Platform to Help…
Supply Chains on the Brink: Why Pharma Can't Afford to Wait Ensuring timely availability of medicines has become one of the toughest challenges in pharma today. While current tariffs on US imports have spared the pharma sector for now, ripple effects across the global economy are here to stay and are intensifying cost pressure. Furthermore, the tightening of regulatory frameworks, growing geopolitical tensions, and climate-related disruptions make the need for agile, proactive site...
PR Newswire
29/05/2025
BMC Medical Highlights Global Innovation in Respiratory Care at ARTP and…
Later in the month, BMC made a high-profile appearance at HOSPITALAR 2025 (May 20–23), Latin America's premier medical trade show. At the event, BMC Medical introduced a comprehensive lineup of respiratory innovations, including the M1 Mini, G3 BPAP series, HFNC devices, RV series ventilators and PAP Link Digital Health solution. Later in the month, BMC made a high-profile appearance at HOSPITALAR 2025 (May 20–23),Latin America'spremier medical trade show. At the event, BMC Medical...
PR Newswire
29/05/2025
Drug Discovery Market Size, Share, CAGR, Growth - 2034
Cervicorn Consulting
29/05/2025
Contract Development And Manufacturing Organization Market Tends 2025-2034
Cervicorn Consulting
29/05/2025
Biologics Market Share & CAGR 2025-2034
Cervicorn Consulting
29/05/2025
Bionical Emas and Pharma Resources Announce Exclusive Global Clinical Trial…
This collaboration strengthens Bionical Emas' position as a trusted supply partner and highlights its continued success in forging impactful global alliances. As the sole distributor, Bionical Emas will streamline access to Pharma Resources' oncology portfolio for pharmaceutical companies, CROs, and clinical trial providers worldwide. This collaboration strengthens Bionical Emas' position as a trusted supply partner and highlights its continued success in forging impactful global alliances...
PR Newswire
29/05/2025
How to Find a Skincare Manufacturer
Start with a Clear Product Vision Start with a Clear Product Vision Before looking for a manufacturer, it's important to know exactly what kind of skincare product you want to create. This includes choosing between private label, white label, or custom formulations. Ridgepole works with all three types, helping brands at every stage of development. Brands should also define their niche—whether that's organic skincare, acne treatment, or luxury beauty. Having a clear direction will...
PR Newswire
29/05/2025
Halia Therapeutics CEO Dr. David Bearss to Deliver Keynote Address at Med…
The keynote will explore how insights from resilient individuals—those who remain disease-free despite genetic risk—are reshaping therapeutic development. Halia's research, grounded in population-scale genomic data, is enabling breakthrough treatments for inflammatory and neurodegenerative diseases. The keynote will explore how insights from resilient individuals—those who remain disease-free despite genetic risk—are reshaping therapeutic development. Halia's research, grounded in...
PR Newswire
29/05/2025
The 137th Canton Fair: Design Innovation Forum Unveils Fashion Trend Report for…
Despite global markets uncertainties, the fashion industry continues to show resilience. The forum addressed how "small-batch, multi-style, and agile" production is becoming the industry norm. Consumer demand is shifting toward personalized, sustainable, and functional fashion, prompting the industry to move from inspiration-driven creation to data-informed design. Despite global markets uncertainties, the fashion industry continues to show resilience. The forum addressed how…
PR Newswire
29/05/2025
Merck's WELIREG Entry Brings New Momentum to Pheochromocytomas and…
Sympathetic tumors often secrete large quantities of catecholamines and are found in the adrenal medulla in about 80% of cases. The remaining 20% are extra-adrenal, typically located along the prevertebral and paravertebral sympathetic ganglia in the chest, abdomen, or pelvis. In 2024, there were 4,900 incident PCPG cases across the 7MM, with numbers expected to rise in the coming years. Sympathetic tumors often secrete large quantities of catecholamines and are found in the adrenal medulla…
PR Newswire
28/05/2025
Nyxoah to Present at the Jefferies Global Healthcare Conference
Nyxoah to Present at the Jefferies Global Healthcare ConferenceMont-Saint-Guibert, Belgium – May 28, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies Global Healthcare Conference, which takes place June 3 – 5, 2025 in New York.Olivier Taelman, Nyxoah's...
Nasdaq GlobeNewswire
28/05/2025
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued…
First Quarter 2025 Financial Highlights First Quarter 2025 Financial Highlights Corporate Highlights and Business Update Management Comments Iris Bincovich, CEO of Innocan Pharma, commented:"We are very pleased with our strong start to 2025, marked by solid results in the first quarter. This positive momentum reflects the dedication and excellence of our team. We continued to deliver meaningful, customer-centric innovation while maintaining a disciplined approach to...
PR Newswire
28/05/2025
Brand Licensing Market to Reach USD 470.55 Billion by 2030, Driven by Growth in…
Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-10C9173/Global_Brand_Licensing_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-10C9173/Global_Brand_Licensing_Market Major Factors Driving the Growth of Brand Licensing Market: The brand licensing market continues to evolve as companies look for innovative ways to extend brand equity and reach new consumer bases. Licensing offers a scalable, low-risk method to enter...
PR Newswire
28/05/2025
Pharmaceutical Lab Equipment Market to Hit USD 15.59 Billion by 2031, Driven by…
Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-32T9116/Global_Pharmaceutical_Lab_Equipment_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-32T9116/Global_Pharmaceutical_Lab_Equipment_Market Major Factors Driving the Growth of Pharmaceutical Lab Equipment Market: The pharmaceutical lab equipment market is undergoing robust growth due to heightened R&D activities, regulatory pressures, and advancements in drug...
PR Newswire
28/05/2025
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…
Leuven, BELGIUM – May 28, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on May 27, 2025, from Atlas Special…
Actusnews Wire
28/05/2025
Compression Therapy Market worth US$5.9 billion by 2030 with 5.5% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146548022 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=146548022 Browse in-depth TOC on "Compression Therapy Market" 400 - Tables 100 - Figures 400 - Pages By Based on Application,the varicose veins segment is the leading segment of the compression therapy market due to its direct link to the rising prevalence of this condition, especially among aging...
PR Newswire
28/05/2025
myTomorrows Launches Expanded Access Management SaaS Platform to Empower…
When no satisfactory treatments are available, EA programs provide critical pathways for physicians treating patients with serious or life-threatening conditions. Yet, navigating the regulatory complexity, documentation, and operational workflows of these programs can be highly burdensome, often resulting in prolonged treatment access and missed opportunities to collect valuable real-world data. When no satisfactory treatments are available, EA programs provide critical pathways for…
PR Newswire
28/05/2025
Metabolon's Untargeted Metabolomics Services Used for Landmark Study Linking a…
Globally, attention-deficit/hyperactivity disorder (ADHD) affects approximately 5–7% of children and adolescents and 2–5% of adults, with variations in prevalence influenced by regional differences in diagnostic practices. Autism spectrum disorder (ASD) has an estimated global prevalence of about 1–2% (around 1 in 100 children), although some recent studies suggest rates up to 2.3%. Boys are diagnosed with autism roughly four times more frequently than girls. Globally,...
PR Newswire
28/05/2025
Altri Comunicati
